These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10083330)

  • 1. The 2C T-cell transgenic mouse: an in vivo model of allospecific cytotoxic T-cell activation and homing.
    Stegall MD; Elices M; Shepard G; Gup C; Ninova D; Ferguson D; Gill RG
    Transplant Proc; 1999; 31(1-2):779. PubMed ID: 10083330
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel model of allograft rejection: immune reconstitution of Rag-1 recipients with 2C transgenic T-cell receptor lymphocytes.
    Ninova D; Dean PG; Deeds M; Stegall MD
    Transpl Int; 2005 Jan; 18(1):101-10. PubMed ID: 15612991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct allorecognition: a mechanism in intrathymic tolerance induction.
    Turvey SE; Hara M; Morris PJ; Wood KJ
    Transplant Proc; 1999; 31(1-2):844. PubMed ID: 10083367
    [No Abstract]   [Full Text] [Related]  

  • 5. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14.
    Seth A; Gote L; Nagarkatti M; Nagarkatti PS
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7877-81. PubMed ID: 1881921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.
    Manning TC; Rund LA; Gruber MM; Fallarino F; Gajewski TF; Kranz DM
    J Immunol; 1997 Nov; 159(10):4665-75. PubMed ID: 9366389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenograft acceptance by masking donor antigens.
    Faustman D; Coe C
    Transplant Proc; 1992 Dec; 24(6):2854-5. PubMed ID: 1465972
    [No Abstract]   [Full Text] [Related]  

  • 9. Murine CD2 mediates cellular immune responses in vivo.
    Bromberg JS; Chavin KD; Lau HT; Altevogt P; Kyewski BA; Guckel B; Naji A; Barker CF
    Transplant Proc; 1991 Feb; 23(1 Pt 1):856-8. PubMed ID: 1671310
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of tolerance to islet and skin allografts by intrathymic inoculation of thymic stromal cell clones in mice.
    Koja S; Doi H; Satomi S; Fujimori K; Takemura M; Ohkohchi N; Miura S; Takeda Y; Morimoto K; Itoh T; Taguchi Y; Okazaki H
    Transplant Proc; 1997; 29(1-2):765-6. PubMed ID: 9123516
    [No Abstract]   [Full Text] [Related]  

  • 11. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
    Nishihara M; Gotoh M; Ohzato H; Ohta Y; Luo Z; Dono K; Umeshita K; Sakon M; Monden M; Yagita H; Okumura K; Miyasaka M
    Transplantation; 1997 Oct; 64(7):965-70. PubMed ID: 9381542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anergic cells generated in vitro suppress rejection response to islet allografts.
    Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
    Transplant Proc; 1999; 31(1-2):623. PubMed ID: 10083265
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of privileged sites and islet transplantation.
    Barker CF; Markmann JF; Posselt AM; Naji A
    Transplant Proc; 1991 Aug; 23(4):2138-42. PubMed ID: 1871831
    [No Abstract]   [Full Text] [Related]  

  • 14. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model.
    Ehl S; Hombach J; Aichele P; Hengartner H; Zinkernagel RM
    J Exp Med; 1997 Apr; 185(7):1241-51. PubMed ID: 9104811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
    Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
    Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolongation of allograft survival by Nippostrongylus brasiliensis is associated with decreased allospecific cytotoxic T lymphocyte activity and development of T cytotoxic cell type 2 cells.
    Liwski R; Zhou J; McAlister V; Lee TD
    Transplantation; 2000 May; 69(9):1912-22. PubMed ID: 10830231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive transfer of CD4 T-cell dependent allograft tolerance.
    Coulombe M; Yang H; Gill RG
    Transplant Proc; 1997; 29(1-2):1166-7. PubMed ID: 9123256
    [No Abstract]   [Full Text] [Related]  

  • 18. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
    Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
    J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature of tolerance induction to peripheral (extrathymic) islet allografts.
    Coulombe M; Lafferty KJ; Gill RG
    Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigating the impact of helminth products on immune responsiveness using a TCR transgenic adoptive transfer system.
    Boitelle A; Scales HE; Di Lorenzo C; Devaney E; Kennedy MW; Garside P; Lawrence CE
    J Immunol; 2003 Jul; 171(1):447-54. PubMed ID: 12817029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.